4

PRIMARY DOCUMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: May 21, 2015
Period of Report: May 21, 2015
Accession Number: 0001465825-15-000003

View Document ↗ View on SEC.gov ↗